Drugs chief replaces long-serving CEO Vasella
New CEO says to maintain strategy
* Considers bid for Alcon minorities as fair
* Q4 net profit $2.3 billion vs forecast $2.4 billion
* Shares up 1.5 percent
See more ›
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- May 2011
- April 2011
- February 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- October 2008
- June 2008
- April 2008
- March 2008
- January 2008
- December 2007
- September 2007
- April 2007
- March 2007
- January 2007
- May 2006
Newsletter
Facebook
LinkedIn
Twitter
Picasa
Flickr
YouTube
